These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings. Mazzola LT; Kelly-Cirino C BMJ Glob Health; 2019; 4(Suppl 2):e001116. PubMed ID: 30899575 [TBL] [Abstract][Full Text] [Related]
3. Current research for a vaccine against Lassa hemorrhagic fever virus. Warner BM; Safronetz D; Stein DR Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299 [TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments. Murphy HL; Ly H Virulence; 2021 Dec; 12(1):2989-3014. PubMed ID: 34747339 [TBL] [Abstract][Full Text] [Related]
5. Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions. Arruda LB; Free HB; Simons D; Ansumana R; Elton L; Haider N; Honeyborne I; Asogun D; McHugh TD; Ntoumi F; Zumla A; Kock R PLOS Glob Public Health; 2023; 3(11):e0002159. PubMed ID: 37939051 [TBL] [Abstract][Full Text] [Related]
6. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives. Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186 [TBL] [Abstract][Full Text] [Related]
7. Vaccine platforms for the prevention of Lassa fever. Purushotham J; Lambe T; Gilbert SC Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485 [TBL] [Abstract][Full Text] [Related]
8. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Cross RW; Heinrich ML; Fenton KA; Borisevich V; Agans KN; Prasad AN; Woolsey C; Deer DJ; Dobias NS; Rowland MM; Lathigra R; Borrega R; Geisbert JB; Garry RF; Branco LM; Geisbert TW Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2304876120. PubMed ID: 37590417 [TBL] [Abstract][Full Text] [Related]
9. Pre-clinical development of a vaccine against Lassa fever. Banadyga L; Stein DR; Qiu X; Safronetz D Can Commun Dis Rep; 2018 Jun; 44(6):139-147. PubMed ID: 31015807 [TBL] [Abstract][Full Text] [Related]
10. Vaccine platforms to control Lassa fever. Lukashevich IS; Pushko P Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941 [TBL] [Abstract][Full Text] [Related]
11. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628 [TBL] [Abstract][Full Text] [Related]
12. Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria. Ogunro BN; Olugasa BO; Kayode A; Ishola OO; Kolawole ON; Odigie EA; Happi C J Epidemiol Glob Health; 2019 Jun; 9(2):125-127. PubMed ID: 31241870 [TBL] [Abstract][Full Text] [Related]